India has been witnessing a good growth in economic and industrial development, which leads to increasing needs on education and calls for a highly diversified human resource. India is many paradigm shifts in the social, business and industrial environment. The onus of making available the skilled human resource lies on system of higher education.
The evolving science in the biotech sector is leading to a demand for high-skilled jobs in India. However, a wide gap currently exists between the quality of human capital available and the needs of the industry. To address this talent defi cit by developing Industry ready human capital for the Biopharma sector and enable global competitiveness of the sector, Dr Manbeena Chawla of BioSpectrum spoke to the captains and HR heads of few leading companies on what the industry needs from the academia and how these companies are addressing the gap of talent and skills sets.
Besides we will be covering the leading biotech, life sciences, and pharmaceutical companies like Dr Reddy’s Labs, Biocon, Cadila Pharmaceucails, Reliance Life Sciences who have set up academy, institutes with an aim to support the industry with skilled manpower and workforce and bridge the gap between industry and academia
The BioSpectrum India edition was launched in March 2003 and is India's first comprehensive biotech business monthly magazine. It provides comprehensive coverage of the exciting happenings in life sciences, which include BioPharma, BioAgriculture, BioInformatics, BioIndustrial, BioSuppliers and BioServices and show cases the emerging Indian entrepreneurships in biotech industry. In a short time BioSpectrum has emerged as the most preferred platform to engage the life sciences industry in India and Asia Pacific. It is also widely accepted by research and academia community. Top key policy makers in the Central and state government use the magazine as a platform to reach out the Indian Biotech Industry. BioSpectrum has columns by Indian's top policy makers, biotechnology professionals, scientists and NGOs. Readers of BioSpectrum are from among the key Policy Makers, Key Executives and the Influencer's in Biotechnology, Pharmaceutical Companies, Research Heads of Clinical Research, Clinical Trials and Contract Mfg Organizations, Educational Institutes, Consultants, Fund Managers etc